title: Survival of patients with primary fallopian tube carcinoma.
abstract: Vaughan MM, Evans BD, Weitzer MJ. Survival of patients with primary fallopian tube carcinoma. Int J Gynecol Cancer 1998; 8: 16-22. Thirty-seven patients with primary fallopian tube carcinoma (PFTC) presenting between 1952 and 1995 were studied. The mean age was 57 years. Seven patients had stage I disease, 20 stage II, 8 stage III, and 2 stage IV. Actuarial 5-year survivals were 73% for stage I, 33% for stage II and 0% for stage III. Stage was a significant predictor of survival at 5 years (Stage I vs. III, P = 0.0006; stage II vs. III, P = 0.0001), however, the majority of patients, even with early stage disease, died of progressive PFTC within 10 years. Grade appeared highly significant at 5 and 10 years (Grades 1 & 2 vs. 3, P = 0. 0023). Neither age nor lymphocytic infiltrate appeared definitely predictive of survival. Eleven of 22 stage II patients received adjuvant treatment. While their median and 5-year survivals were superior to those not receiving adjuvant treatment (51 vs. 30 months, 47% vs. 22%), the difference was not statistically significant. This retrospective analysis confirms the poor prognosis of patients with PFTC. The majority of patients, even with early stage tumors, eventually succumb to their disease. Larger studies may identify a group of patients potentially curable with surgery alone, and clarify the role of adjuvant therapy.
authors.affiliation: Department of Medicine, The Royal Marsden Hospital, Fulham Rd, London, U.K; Oncology Unit, Auckland Hospital, Park Rd, Auckland; Department of Histopathology, Greenlane Hospital, Greenlane, Auckland, New Zealand.
authors.forename: M. M.
authors.initials: MM
authors.lastname: Vaughan
authors.forename: B. D.
authors.initials: BD
authors.lastname: Evans
authors.forename: J.
authors.initials: J
authors.lastname: Baranyai
authors.forename: M. J.
authors.initials: MJ
authors.lastname: Weitzer